drugset / Trial / NCT07446153

A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

NCT07446153 ↗

Phase 1/2 Recruiting 282 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This study is an open, multicenter, Phase I/II clinical trial, divided into three stages: dose escalation, dose expansion and efficacy expansion.

Timeline

Start
2026-03-19
Primary completion
2028-12
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-8364 Unknown — —

Indications